Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition

1.5 / 5 stars · 27/93 Roast Me

VYOME HOLDINGS, INC. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition

VYOME HOLDINGS, INC. (HIND) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $16.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.

Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital

us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2021-05-12

  • VYOME HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2020-06-30 was $2.00K, a 86.67% decline year-over-year.
  • VYOME HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2020-03-31 was $14.00K, a 0.00% change year-over-year.
  • VYOME HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2019-09-30 was $14.00K, a 0.00% change year-over-year.
  • VYOME HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2019-06-30 was $15.00K, a 0.00% change year-over-year.
  • VYOME HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2020 was $16.00K, a 72.41% decline from fiscal 2019.
  • VYOME HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2019 was $58.00K, a 1.75% increase from fiscal 2018.
  • VYOME HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2018 was $57.00K, a 50.86% decline from fiscal 2017.
  • VYOME HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2017 was $116.00K.
Period endAPIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 monthAPIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 monthAPIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 monthAPIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month
2020-12-31$16.00K
10-K · filed 2021-03-12
2020-06-30$2.00K
10-Q · filed 2020-11-06
$16.00K
derived: sum of 2 quarters · filed 2021-05-12
2020-03-31$14.00K
10-Q · filed 2021-05-12
2019-12-31$58.00K
10-K · filed 2021-03-12
2019-09-30$14.00K
10-Q · filed 2020-11-06
$29.00K
derived: sum of 2 quarters · filed 2020-11-06
$43.00K
derived: sum of 3 quarters · filed 2020-11-06
2019-06-30$15.00K
10-Q · filed 2020-11-06
$29.00K
derived: sum of 2 quarters · filed 2020-11-06
2019-03-31$14.00K
10-Q · filed 2020-11-06
2018-12-31$57.00K
10-K · filed 2020-02-27
2018-09-30$14.00K
10-Q · filed 2019-11-08
$29.00K
derived: sum of 2 quarters · filed 2019-11-08
$43.00K
derived: sum of 3 quarters · filed 2019-11-08
2018-06-30$15.00K
10-Q · filed 2019-11-08
$29.00K
derived: sum of 2 quarters · filed 2019-11-08
2018-03-31$14.00K
10-Q · filed 2019-11-08
2017-12-31$116.00K
10-K · filed 2019-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36